February 20, 2018 12:33 PM ET

Pharmaceuticals

Company Overview of ECI, Inc.

Company Overview

ECI, Inc. operates a drug discovery platform company that develops original medicines and treatments for cancer and inflammatory diseases based on analysis of human cell function. ECI, Inc. was formerly known as Effector Cell Institute Inc. and changed its name to ECI, Inc. in August 2008. The company was founded in 1999 and is headquartered in Tachikawa, Japan.

1st floor of Daiichi Toyo Building

3-17 Shibasaki cho

2-chome Shibasaki-cho

Tachikawa,  190-0023

Japan

Founded in 1999

23 Employees

Phone:

81 42 595 8970

Fax:

81 42 595 8971

Key Executives for ECI, Inc.

Chief Executive Officer, President and Director
Age: 74
Senior Managing Director and Manager of Corporate Administration Department
Age: 67
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
ABsize Inc. Asia
AccuRna, Inc. Asia
ACE Japan, L.L.C. Asia
AdipoSeeds Co., Ltd. Asia
AETAS Pharma Co.,Ltd. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ECI, Inc., please visit www.effectorcell.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.